Rush Ryan Bradford - 17 Dec 2024 SCHEDULE 13G Report for Adverum Biotechnologies, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (ADVM)

Filing Manager
Rush Ryan Bradford
Reporting Manager
Rush Ryan Bradford
Security
Adverum Biotechnologies, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934
Symbol
ADVM
Shares outstanding
20,588,235 shares
Disclosed Ownership
1,050,000 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
17 Dec 2024, 17:11:11 UTC
Date of event
17 Dec 2024
SEC
View on sec.gov

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rush Ryan Bradford 5.1% 1,050,000 1,050,000 1,050,000 Rush Ryan Bradford Individual